Login / Signup

Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients.

Alessio GerussiCristina RigamontiChiara EliaNora CazzagonAnnarosa FloreaniRoberta PozziPietro PozzoniErnesto ClaarLuisa PasuloStefano FagiuoliLaura CristoferiMarco CarboneInvernizzi Pietro
Published in: Hepatology communications (2020)
Patients under immunosuppressive therapy for AIH developing COVID-19 show a disease course presumptively similar to that reported in non-immunosuppressed population. These data might help medical decision when dealing with SARS-CoV-2 infection in immunocompromised patients.
Keyphrases
  • coronavirus disease
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • prognostic factors
  • healthcare
  • intensive care unit
  • electronic health record
  • deep learning
  • big data
  • respiratory failure